Regeneron also earns spot on Dow Jones Best-in-Class North America Index for six consecutive years Recognition complements the company’s recent announcement that it will provide its new gene therapy...
DENVER, May 07, 2026 (GLOBE NEWSWIRE) -- ( www.247marketnews.com and NeOnc Technology) - The biotech and pharma sector is entering one of its most pivotal periods in years, where insider conviction,...
5 Must-Read Analyst Questions From Regeneron’s Q1 Earnings Call
Despite Intellia's severe stock drop from its 2021 peak, Cathie Wood is buying big.
Dupixent showed significant and clinically meaningful improvements in both esophageal distensibility as well as disease-related structural changes and inflammation in the esophagus in adult patients with...
1 Cash-Producing Stock Worth Investigating and 2 Facing Headwinds
REGN Q1 Deep Dive: Product Expansion Drives Growth, Margin Pressures Draw Scrutiny
Why Regeneron (REGN) Shares Are Getting Obliterated Today